ACOR - Acorda Therapeutics' (ACOR) CEO Ron Cohen on Q3 2018 Results - Earnings Call Transcript
Acorda Therapeutics, Inc. (ACOR)
Q3 2018 Earnings Conference Call
October 31, 2018 8:30 A.M. ET
Executives
Felicia Vonella - Executive Director-Investor Relations
Ron Cohen - Chief Executive Officer
Analysts
Carmen Augustine - JPMorgan
Kelechi Chikere - Jefferies
Phil Nadeau - Cowen and Company
Ross Weinreb - Goldman Sachs
Laura Chico - Raymond James
Ben Burnett - Stifel
Raghuram Selvaraju - H.C. Wainwright
Silvan Turkcan - Oppenheimer
Ken Trbovich - Janney
Presentation
Operator
Welcome to the Acorda Therapeutics Third Quarter 2018 Update. At this time, all participants are in a listen-only mode. There will be a